Member Info for DP64

Why it is assigned to Provexis and then again DSM? So if By-Health would like to make an offer they also need to negotiate with DSM as well!!
2019-06-19
Assigned to PROVEXIS NATURAL PRODUCTS LIMITED
2019-06-19
Assigned to DSM IP ASSETS B.V.

Following please find various TYK2/CHK1/Small Molecule Links Related to Sareum through out the whole week for Sunday reading

https://www.the-dermatologist.com/news/jaks-exciting-potential-derms-clinical-trials
https://www.the-dermatologist.com/news/margitta-worm-md-topical-pan-jak-inhibitor-chronic-hand-eczema
https://www.the-dermatologist.com/news/margitta-worm-md-topical-pan-jak-inhibitor-chronic-hand-eczema

https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01511

https://medicalxpress.com/news/2020-12-defeating-pathological-autoimmunity-kinase-inhibition.html
https://neighborwebsj.com/uncategorized/1624337/impact-of-covid-19-on-non-receptor-tyrosine-protein-kinase-tyk2-market-2021-size-growth-demand-opportunities-forecast-to-2027-array-biopharma-inc-bristol-myers-squibb-company-nimbus-the/

https://www.pnas.org/content/116/27/13374
https://www.merckgroup.com/en/research/healthcare-pipeline.html
https://www.edisongroup.com/publication/starting-to-tick-the-right-boxes/28690/
https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01511
http://practicalfragments.blogspot.com/2021/01/fragments-vs-tnf-advanced-with.html
https://www.abstractsonline.com/pp8/#!/9045/session/810

https://www.edisongroup.com/publication/starting-to-tick-the-right-boxes/28690/
https://www.pharmiweb.com/press-release/2021-01-21/edison-group-democratises-access-to-booming-healthcare-investment-with-stars-of-science-business-and-broadcasting

https://endpts.com/biotech-voices-revisiting-the-cytokine-storm-in-ards-the-painful-wait-for-anti-inflammatory-drugs-targets-that-solve-covid-19-deaths/
https://www.businesswire.com/news/home/20210127005184/en/Pfizer-Shares-Co-Primary-Endpoint-Results-from-Post-Marketing-Required-Safety-Study-of-XELJANZ%C2%AE-tofacitinib-in-Subjects-with-Rheumatoid-Arthritis-RA
https://endpts.com/pfizers-xeljanz-flunks-its-post-marketing-safety-study-renewing-harsh-questions-for-jak-class/

https://pubmed.ncbi.nlm.nih.gov/33494096/
https://www.frontiersin.org/articles/10.3389/fonc.2018.00287/full
https://ard.bmj.com/content/79/Suppl_1/252.1
https://clinicaltrials.gov/ct2/show/NCT04243083

https://www.biospace.com/article/ibri-researchers-find-opportunity-to-repurpose-drugs-for-type-1-diabetes/
https://www.nature.com/articles/s41598-021-82139-x
https://www.biorxiv.org/content/10.1101/2020.12.26.424381v2.full

https://seekingalpha.com/article/4401398-sierra-oncology-time-to-enter-for-big-pie

It seems the Market is taking it a very +ve, which a very good sign.

Azz2020,
Great initiative. Fully agreed it is not driven only money, however it also should be ethical also when there is a treatment available make use of it those who need it. Hope your e-mail start the ball rolling.

Is the presentation available anywhere? If so could someone put the link here?

It is nice to see COVID-19 is mention in their website
https://www.fruitflowplus.com/

Hi Stach,
Thanks for the thoughtful post. Hope you will keep well and fine.

Fruitflow could help these COVID sufferer
https://nyti.ms/3qzCn1O

Steve,
I do not think anyone could beat gixer. He is our PXS hero in this board. IF should appoint in PXS for promoting fruitflow.

I think they need start to advertise through various channels like RNS that there is a link between and COVID-19 and Fruitflow. Once they start advertise then people will show interest. I know they need to do a full clinical trail to make a formal claim that will probably rocket the SP. However they simply could provide a RNS. Please look at Sareum. Recently there is a publication in nature magazine and Sareum provide a RNS based on that publication. I hope IF is following up all these links rather than taking it is a bit easy as he got £1m in bank.

Thoth2,
Great news. Fully agreed. We are in something, which could be phenomenal and will change our life altogether, especially your dream boat. We are going to have a great party in your dream boat.

What is happening with the SP this morning?

gixer,
I also hope so there is a valid reason for not referencing that paper not IF is lazy to do anything as he got £1m in the bank account. I strongly believe it is worth for a RNS to show the world that we have a wonderful product fruitflow to help people with COVID-19. Hope there is a fight between DSM and BY-Health to take the COVID link in future as DSM's contract is going to end next hear and BY-Health spent a lots of their money in 9 clinical trials. Very interesting time ahead.

Thoth2,
Great find our in-house expert. Hope guys in Sareum are following this board as well to help their research.

gixer,
Great find. I think you should be in PXS board to promote the great product fruitflow. Now they need to tweet that Fruitflow will hep people with COVID-19 and refer that paper Asim recently published.

gixer,
Good find. Probably we need to wait for their explanation.

W£,
Great find. Hope our man IF is following up all these wonderful links. They could appoint either you or gixer for finding all these useful information. Depression is very important in current scenario.

Basser1,
Many thanks for your findings of wonderful information.

It seems the SP is holding or going slightly up with very little volume, which probably a very good sign. Surprisingly no news about the new investor. So it is not clear how much SL bought and how much all the other new investors (IF's friends) bought. Very interesting time ahead.

Num4,
Many thanks for the wonderful find, which gives us more confidence about SAR. Looks like we got lots of news to come in near future.